Nalmefene Hydrochloride Oral Tablets bulk supplier for pharma manufacturers

Nalmefene Hydrochloride Oral Tablets 18 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets

Available Strengths: 18 mg

Reference Brands: Selincro(EU)

Nalmefene is an opioid receptor modulator that primarily acts as an antagonist at μ- and δ-opioid receptors and partial agonist at κ-opioid receptors. It reduces the rewarding effects of alcohol, helping to decrease consumption. Clinically, it's used in the management of alcohol dependence in adults with high-risk drinking behaviors.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Nalmefene Hydrochloride Tablets are approved in the EU for the reduction of alcohol consumption in adult patients with alcohol dependence, under brand names like Selincro®. They are prescription-only and regulated by the European Medicines Agency (EMA) under centralized procedures. In the USA, as of now, Nalmefene tablets are not FDA-approved for alcohol dependence, though clinical trials have been conducted. EU regulatory approval includes risk management plans and post-marketing surveillance. Manufacturing requires adherence to EU-GMP guidelines. Pharmatradz.com connects you with compliant suppliers of Nalmefene Hydrochloride tablets and other psychiatric formulations for global B2B sourcing and regulatory insight.

Nalmefene Hydrochloride Oral Tablets — third party manufacturing & bulk supply

Nalmefene Hydrochloride Oral Tablets 18 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Nalmefene Hydrochloride Oral Tablets is supplied as Oral Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Nalmefene Hydrochloride Oral Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Nalmefene Hydrochloride Oral Tablets →

Back to Listing

Frequently Asked Questions

Nalmefene Hydrochloride Oral Tablets is listed as Oral Tablets in 18 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Nalmefene Hydrochloride Oral Tablets is referenced against Selincro(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.